Create a free QxMD account to take advantage of the features offered by Read like saving your papers and creating collections.

Get Started

JOURNAL ARTICLE

Aspergillus fumigatus strains with mutations in the cyp51A gene do not always show phenotypic resistance to itraconazole, voriconazole, or posaconazole

Pilar Escribano, Sandra Recio, Teresa Peláez, Emilio Bouza, Jesús Guinea

Antimicrobial Agents and Chemotherapy 2011, 55 (5): 2460-2

We performed molecular identification of 98 Aspergillus fumigatus complex isolates with MICs of 1 to 4 μg/ml for itraconazole and searched for the presence of mutations in cyp51A. Most of the isolates (91%) belonged to A. fumigatus sensu stricto. We found 14 different mutations in nine isolates at codons different from G54, M220, G138, G448, and L98. We report new mutations at positions 165, 262, 479, and 497 (silent). The role of these mutations should be analyzed.

Full Text Links

Find Full Text Links for this Article

Discussion

You are not logged in. Sign Up or Log In to join the discussion.

Related Papers

Azole preexposure affects the Aspergillus fumigatus population in patients. Alexandre Alanio, Odile Cabaret, Emilie Sitterlé, Jean-Marc Costa, Sylvain Brisse, Catherine Cordonnier, Stéphane Bretagne Antimicrobial Agents and Chemotherapy 2012, 56 (9): 4948-50

Epidemiological cutoff values for azoles and Aspergillus fumigatus based on a novel mathematical approach incorporating cyp51A sequence analysis. J Meletiadis, E Mavridou, W J G Melchers, J W Mouton, P E Verweij Antimicrobial Agents and Chemotherapy 2012, 56 (5): 2524-9

cyp51A-Based mechanisms of Aspergillus fumigatus azole drug resistance present in clinical samples from Germany. Oliver Bader, Michael Weig, Utz Reichard, Raimond Lugert, Martin Kuhns, Martin Christner, Jürgen Held, Silke Peter, Ulrike Schumacher, Dieter Buchheidt, Kathrin Tintelnot, Uwe Groß Antimicrobial Agents and Chemotherapy 2013, 57 (8): 3513-7

In vitro susceptibility of Aspergillus fumigatus to isavuconazole: correlation with itraconazole, voriconazole, and posaconazole. Lea Gregson, Joanne Goodwin, Adam Johnson, Laura McEntee, Caroline B Moore, Malcolm Richardson, William W Hope, Susan J Howard Antimicrobial Agents and Chemotherapy 2013, 57 (11): 5778-80

In Vitro Activity of ASP2397 against Aspergillus Isolates with or without Acquired Azole Resistance Mechanisms. Maiken Cavling Arendrup, Rasmus Hare Jensen, Manuel Cuenca-Estrella Antimicrobial Agents and Chemotherapy 2016, 60 (1): 532-6

Frequency and evolution of Azole resistance in Aspergillus fumigatus associated with treatment failure. Susan J Howard, Dasa Cerar, Michael J Anderson, Ahmed Albarrag, Matthew C Fisher, Alessandro C Pasqualotto, Michel Laverdiere, Maiken C Arendrup, David S Perlin, David W Denning Emerging Infectious Diseases 2009, 15 (7): 1068-76

Mutations in the cyp51A gene and susceptibility to itraconazole in Aspergillus fumigatus serially isolated from a patient with lung aspergilloma. Jian Chen, Houmin Li, Ruoyu Li, Dingfang Bu, Zhe Wan Journal of Antimicrobial Chemotherapy 2005, 55 (1): 31-7

In vitro acquisition of secondary azole resistance in Aspergillus fumigatus isolates after prolonged exposure to itraconazole: presence of heteroresistant populations. Pilar Escribano, Sandra Recio, Teresa Peláez, Milagros González-Rivera, Emilio Bouza, Jesús Guinea Antimicrobial Agents and Chemotherapy 2012, 56 (1): 174-8

Quantitative Analysis of Single-Nucleotide Polymorphism for Rapid Detection of TR34/L98H- and TR46/Y121F/T289A-Positive Aspergillus fumigatus Isolates Obtained from Patients in Iran from 2010 to 2014. Faezeh Mohammadi, Seyed Jamal Hashemi, Jan Zoll, Willem J G Melchers, Haleh Rafati, Parvin Dehghan, Sasan Rezaie, Ali Tolooe, Yalda Tamadon, Henrich A van der Lee, Paul E Verweij, Seyedmojtaba Seyedmousavi Antimicrobial Agents and Chemotherapy 2016, 60 (1): 387-92

Epidemiological cutoffs and cross-resistance to azole drugs in Aspergillus fumigatus. Juan Luis Rodriguez-Tudela, Laura Alcazar-Fuoli, Emilia Mellado, Ana Alastruey-Izquierdo, Araceli Monzon, Manuel Cuenca-Estrella Antimicrobial Agents and Chemotherapy 2008, 52 (7): 2468-72

Make the most of Read.
Download the mobile app.

Want full text access to this paper?

Use Read by QxMD to access full text via your institution or open access sources.

Read also provides personalized recommendations to keep you up to date in your field.

Existing User

New to Read

Aspergillus fumigatus strains with mutations in the cyp51A gene do not always show phenotypic resistance to itraconazole, voriconazole, or posaconazole

Discussion

Related Papers

Want full text access to this paper?

Save your favorite articles in one place with a free QxMD account.

Read

Search Tips